MENUMENU
  • About Us
    • Statement From CEO
    • Our Leadership
    • Partnerships
  • Programs
    • Personal Cancer Immunotherapy
    • The Clean Super Vaccine
    • Publications
  • News & Media
  • Contact Us
    • Contact Us
    • Careers
MENUMENU
  • About Us
    • Statement From CEO
    • Our Leadership
    • Partnerships
  • Programs
    • Personal Cancer Immunotherapy
    • The Clean Super Vaccine
    • Publications
  • News & Media
  • Contact Us
    • Contact Us
    • Careers
  •  
  • Uncategorized

AIVITA Biomedical CEO Hans Keirstead, Ph.D. to Present as Distinguished Speaker at Upcoming Stem Cell Summit 2017

AIVITA Biomedical to Present Skin Care Technology and Products at 15th Annual South Beach Symposium

AiVita Biomedical Awarded NIH R01 Grant for Development of 3D-Transplantable ‘Retinas’

AiVita Highlights Ovarian Cancer Therapy at Cancer Stem Cell Conference 2016

AiVita CEO Comments on Recent Milestone Achievements in Asterias’ SCiStar Trial for Spinal Cord Injury

AiVita Biomedical Awarded CIRM Grant for Development of 3D-Transplantable ‘Retinas’

AiVita Biomedical Receives FDA Approval for Phase II Ovarian Cancer Treatment

  • Previous
  • 10
  • 11
  • 12

AIVITA Biomedical is a biotechnology company developing personalized vaccines that target infectious diseases and tumor-initiating cells — the seed of all cancers — using our autologous cell platform. We leverage our unique expertise in stem cell growth and directed, high-purity differentiation to develop safe, efficient and economical manufacturing processes for therapeutic development in cancer, infectious disease and other fields.

Recent News

  • AIVITA Biomedical Strengthens Board of Directors with Appointment of Global Health and Vaccine Readiness Leader Larry Brilliant
  • AIVITA Biomedical Nominated for 2026 Prix Galien USA Award
  • AIVITA Biomedical Licenses Novel Skincare Formulations to Global Skincare Retailer LevEllis
  • AIVITA Biomedical CEO Dr. Hans Keirstead and CMO Dr. Robert Dillman to Speak and Participate in Keynote Panel at Festival of Biologics USA
  • AIVITA Biomedical CEO Dr. Hans Keirstead to Join Keynote Panel for AI in Public Health at World Vaccine Congress

Site Navigation

  • About Us
  • Programs
  • News & Media
  • Contact Us
Copyright © 2023 | AIVITA Biomedical, Inc.